Search hospitals > Louisiana > Baton Rouge
Ochsner Health Center-Summa
Claim this profileBaton Rouge, Louisiana 70809
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Melanoma
86 reported clinical trials
4 medical researchers
Summary
Ochsner Health Center-Summa is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Melanoma and other specialties. Ochsner Health Center-Summa is involved with conducting 86 clinical trials across 236 conditions. There are 4 research doctors associated with this hospital, such as Marc Matrana, MD, John Cole, MD, Ryan P. Griffin, and Burke J. Brooks.Area of expertise
1Lung Cancer
Global LeaderStage I
Stage II
Stage III
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Marc Matrana, MDOchsner Medical Center Jefferson5 years of reported clinical research
Expert in Lung Cancer
Studies Cancer
26 reported clinical trials
65 drugs studied
John Cole, MDOchsner Medical Center Jefferson8 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
11 reported clinical trials
40 drugs studied
Ryan P. GriffinMedical Center of Baton Rouge8 years of reported clinical research
Studies Thyroid Cancer
Studies Fallopian Tube Carcinosarcoma
1 reported clinical trial
2 drugs studied
Burke J. BrooksOchsner Health Center-Summa12 years of reported clinical research
Studies Colorectal Cancer
1 reported clinical trial
2 drugs studied
Clinical Trials running at Ochsner Health Center-Summa
Lung Cancer
Non-Small Cell Lung Cancer
ALK Gene Rearrangement
Cardiotoxicity
Breast cancer
Cutaneous Melanoma
Anaplastic Large Cell Lymphoma
Brain Tumor
Breast Cancer
Brain Metastasis
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Osimertinib
for Non-Small Cell Lung Cancer
This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back after a period of improvement (recurrent). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 242 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ochsner Health Center-Summa?
Ochsner Health Center-Summa is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Non-Small Cell Lung Cancer, Melanoma and other specialties. Ochsner Health Center-Summa is involved with conducting 86 clinical trials across 236 conditions. There are 4 research doctors associated with this hospital, such as Marc Matrana, MD, John Cole, MD, Ryan P. Griffin, and Burke J. Brooks.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.